Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or High-Risk Myelodysplastic Syndrome: Randomized Phase II Study

NCT04482894 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT04482894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04482894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or High-Risk Myelodysplastic Syndrome: Randomized Phase II Study
Lead sponsor
University of Virginia
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 19, 2020
Completion date
June 1, 2027
Enrollment
105 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

all, adult, aml, adult, leukemia, acute, myelodysplastic syndromes